2BB score and signals
Skye Bioscience, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 37 | Low |
| Momentum | 68 | Improving |
| Financial strength | 1 | Very Weak |
| Quality | 40 | Normal |
| Risk | 64 | High |
2BBBullish & Bearish
Skye Bioscience, Inc. (SKYE) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 26 out of 100.
Skye Bioscience, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 37 | Low |
| Momentum | 68 | Improving |
| Financial strength | 1 | Very Weak |
| Quality | 40 | Normal |
| Risk | 64 | High |
| Founded | 2011 |
| Employees | 2 |
| 52-week range | $0.30 – $4.99 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -1.9363 | — | $0.00 |
| 2026-08-05 | — | -0.2518 | — | $0.00 |
| 2026-05-11 | -0.32 | -0.3153 | $0.00 | $0.00 |
| 2026-03-10 | -0.36 | -0.3025 | $0.00 | $0.00 |